Molecular Formula | C19H20N4O |
Molar Mass | 320.3883 |
Melting Point | 144 °C |
Solubility | 10 mM in DMSO |
Storage Condition | -20℃ |
introduction | as the best PARP inhibitor of the same kind, niraparib toluenesulfonate has excellent clinical efficacy, once-a-day administration regimen and superior pharmacokinetic characteristics, and has the advantages of being able to cross the blood-brain barrier. |
indications | niraparib toluenesulfonate can be used for maintenance treatment in adult patients with recurrent epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancer (requiring complete or partial remission of platinum-based chemotherapy). |